title: [Strains and species differences in experimental hyperlipidemia].
abstract: Experimental hyperlipidemia was induced in ddY, C57BL, BALB and ICR strain mice and in Wistar rats. By feeding the animals a high cholesterol diet (HCD) for 2 weeks or by administering a high fat emulsion for a week, plasma level of total cholesterol (TC) increased in these animals. The increment of TC in mice was less than that of TC in rats. In rats, plasma level of triglyceride (TG) increased, but it decreased in mice of all these strains. Plasma level of high density lipoprotein cholesterol (HDL-C) decreased in rats and mice except BALB mice. By feeding these animals a HCD, the relative liver weight increased in rats and mice. In rats, clofibrate (CF), 100 mg/kg/day, decreased TC and TG and increased HDL-C, and nicotinic acid (NA), 100 mg/kg/day, decreased and increased HDL-C. However, in mice, CF decreased TC only in ICR mice fed a HCD. The hypolipidemic effects of gemfibrozil, LK-903 and pirozadil were also studied in rats and ICR mice.
authors.forename: S
authors.initials: S
authors.lastname: Morishita
authors.forename: T
authors.initials: T
authors.lastname: Saito
authors.forename: Y
authors.initials: Y
authors.lastname: Mishima
authors.forename: A
authors.initials: A
authors.lastname: Mizutani
authors.forename: Y
authors.initials: Y
authors.lastname: Hirai
authors.forename: S
authors.initials: S
authors.lastname: Koyama
authors.forename: M
authors.initials: M
authors.lastname: Kawakami
mesh_terms: D000818:Animals; D002994:Clofibrate / Q000627:therapeutic use; D004195:Disease Models, Animal; D015248:Gemfibrozil; D005989:Glycerides / Q000627:therapeutic use; D006949:Hyperlipidemias / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008055:Lipids / Q000097:blood; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D008815:Mice, Inbred Strains; D009525:Niacin / Q000627:therapeutic use; D010421:Pentanoic Acids / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D051381:Rats; D011919:Rats, Inbred Strains; D013045:Species Specificity
chemical_list: D005989:Glycerides; D000960:Hypolipidemic Agents; D008055:Lipids; D010421:Pentanoic Acids; D011725:Pyridines; D009525:Niacin; C017974:methyl-p-myristyloxycinnamic acid 1-monoglyceride; C015453:pirozadil; D002994:Clofibrate; D015248:Gemfibrozil